Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma
Publication

Publications

Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma

Title
Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma
Type
Article in International Scientific Journal
Year
2016
Authors
Ferreira, LB
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Eloy, C
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Pestana, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Lyra, J
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Moura, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Prazeres, H
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Tavares, C
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Sobrinho Simoes, M
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Gimba, E
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 174
Pages: 551-561
ISSN: 0804-4643
Publisher: BioScientifica Ltd.
Other information
Authenticus ID: P-00K-AZV
Abstract (EN): Background: Osteopontin (OPN) or secreted phosphoprotein 1 (SPP1) is a matricellular glycoprotein whose expression is elevated in various types of cancer and has been shown to be involved in tumourigenesis and metastasis in many malignancies, including follicular cell-derived thyroid carcinomas. Its role in C-cell-derived thyroid lesions and tumours remains to be established. Objective: The objective of this study is to clarify the role of OPN expression in the development of medullary thyroid carcinoma (MTC). Methods: OPN expression was analysed in a series of 116 MTCs by immunohistochemistry and by qPCR mRNA quantification of the 3 OPN isoforms (OPNa, OPNb and OPNc) in six cases from which fresh frozen tissue was available. Statistical tests were used to evaluate the relationship of OPN expression and the clinicopathological and molecular characteristics of patients and tumours. Results: OPN expression was detected in 91 of 116 (78.4%) of the MTC. We also observed high OPN expression in C-cell hyperplasia as well as in C-cells scattered in the thyroid parenchyma adjacent to the tumours. OPN expression was significantly associated with smaller tumour size, PTEN nuclear expression and RAS status, and suggestively associated with non-invasive tumours. OPNa isoform was expressed significantly at higher levels in tumours than in non-tumour samples. OPNb and OPNc presented similar levels of expression in all samples. Furthermore, OPNa isoform overexpression was significantly associated with reduced growth and viability in the MTC-derived cell line (TT). Conclusion: The expression of OPN in normal C-cells and C-cell hyperplasia suggests that OPN is a differentiation marker of C-cells, rather than a marker of biological aggressiveness in this setting. At variance with other cancers, OPN expression is associated with good prognostic features in MTC.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 11
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis (2020)
Another Publication in an International Scientific Journal
van Hulsteijn, LT; Pasquali, R; Casanueva, F; Haluzik, M; Ledoux, S; Monteiro, M; Salvador, J; Santini, F; Toplak, H; Dekkers, OM
Non-invasive follicular thyroid neoplasm with papillary-like nuclear feature: clinical, pathological, and molecular update 5 years after the nomenclature revision (2023)
Another Publication in an International Scientific Journal
Melo, M; Ventura, M; Cardoso, L; da Rocha, AG; Paiva, I; Sobrinho-Simoes, M; Soares, P
ENDOCRINE TUMOURS Genetic predictors of thyroid cancer outcome (2016)
Another Publication in an International Scientific Journal
Tavares, C; Melo, M; Manuel Cameselle Teijeiro, JM; Soares, P; Sobrinho Simoes, M
Diagnostic tests for Cushing's syndrome differ from published guidelines: Data from ERCUSYN (2017)
Another Publication in an International Scientific Journal
Valassi, E; Franz, H; Brue, T; Feelders, RA; Netea Maier, R; Tsagarakis, S; Webb, SM; Yaneva, M; Reincke, M; Droste, M; Komerdus, I; Maiter, D; Kastelan, D; Chanson, P; Pfeifer, M; Strasburger, CJ; Tóth, M; Chabre, O; Tabarin, A; Krsek, M...(mais 76 authors)
Cell cycle regulation in adrenocortical carcinoma (2018)
Another Publication in an International Scientific Journal
Pereira, SS; Monteiro, M; Bourdeau, I; Lacroix, A; Pignatelli, D

See all (22)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-28 at 17:37:55 | Privacy Policy | Personal Data Protection Policy | Whistleblowing